Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,919 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatment.
Hatanaka T, Kakizaki S, Nagashima T, Ueno T, Namikawa M, Tojima H, Takizawa D, Naganuma A, Arai H, Sato K, Harimoto N, Shirabe K, Uraoka T. Hatanaka T, et al. Among authors: sato k. Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):65-72. doi: 10.51821/84.1.109. Acta Gastroenterol Belg. 2021. PMID: 33639695 Free article.
Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study.
Suzuki Y, Naganuma A, Hoshino T, Hatanaka T, Ueno T, Namikawa M, Takizawa D, Arai H, Suzuki H, Takagi H, Tojima H, Yamazaki Y, Sato K, Kakizaki S, Uraoka T. Suzuki Y, et al. Among authors: sato k. Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):57-63. doi: 10.51821/84.1.357. Acta Gastroenterol Belg. 2021. PMID: 33639694 Free article.
14,919 results
You have reached the last available page of results. Please see the User Guide for more information.